Trial Profile
Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2024
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Liraglutide (Primary) ; Semaglutide (Primary)
- Indications Diabetic cardiomyopathy; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LICAS-MR
- 16 Feb 2024 Status changed from recruiting to completed.
- 02 Jan 2023 Planned End Date changed from 1 Jul 2024 to 1 Jan 2025.
- 02 Jan 2023 Planned primary completion date changed from 1 Oct 2023 to 1 Apr 2024.